U.S. FDA approves Verastem's cancer therapy-March 2024-www.financetom.com

U.S. FDA approves Verastem's cancer therapy

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

U.S. FDA approves Verastem's cancer therapy

May 26, 2025 4:23 AM

May 8 (Reuters) - The U.S. Food and Drug Administration

has approved Verastem's ( VSTM ) combination therapy for

patients with a type of ovarian cancer who have received prior

treatment, the regulator said on Thursday.

Previous page： Market Chatter: General Mills in Talks With French Dairy Companies to Sell North American Yogurt Business for $2 Billion Next page： Trump's plan to hike tariffs would spike shipping costs, just like in 2018, experts say

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Market Chatter: General Mills in Talks With French Dairy Companies to Sell North American Yogurt Business for $2 Billion

Sep 12, 2024

06:24 AM EDT, 09/12/2024 (MT Newswires) -- General Mills ( GIS ) is in advanced discussions to sell its North American yogurt business, which includes the Yoplait brand, for more than $2 billion, Bloomberg reported Thursday, citing unnamed people with knowledge of the matter. The company is in discussion to sell the US and Canadian operations to French dairy companies...

Trump's plan to hike tariffs would spike shipping costs, just like in 2018, experts say

Sep 12, 2024

LOS ANGELES, Sept 12 (Reuters) - U.S. presidential contender Donald Trump's plan to hike tariffs on imports if he is elected back to the White House in November would send cargo rates soaring and accelerate inflation, just like it did during his 2017-21 term, shipping and retail experts said. Trump, who is running against Democratic Vice President Kamala Harris in...

Aura Biosciences' Eye Cancer Therapy Shows Promise in Mid-Stage Study -- Shares Rise Pre-Bell

Sep 12, 2024

07:24 AM EDT, 09/12/2024 (MT Newswires) -- Aura Biosciences ( AURA ) said Thursday that a mid-stage study of its experimental therapy, bel-sar, to treat early-stage choroidal melanoma showed positive results. The study of bel-sar demonstrated an 80% tumor control rate among late-stage-eligible patients, with tumor growth stopping completely in responders. The company said 90% of patients in therapy showed...

US auto safety regulator opens probe into some VinFast cars

Sep 12, 2024

Sept 12 (Reuters) - The U.S. National Highway Traffic Safety Administration (NHTSA) has opened a preliminary investigation into some electric vehicles manufactured by Vietnam's VinFast, it said on Thursday, over reports that the Lane Keep Assist System was not functioning correctly. The investigation into about 3,118 VinFast vehicles came after the regulator identified 14 reports from drivers of VinFast 2023...